Skip to main content
. 2022 Aug 4;108(2):420–432. doi: 10.3324/haematol.2022.281585

Figure 1.

Figure 1.

Flowchart describing the selection and distribution of analyzed patients. AML: acute myeloid leukemia; HCT: hematopoietic cell transplantation; MFC: multiparameter flow cytometry; MRD: measurable residual disease.